Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2010
05/20/2010WO2010055024A1 Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same
05/20/2010WO2010054826A1 Antisense compositions and methods of making and using same
05/20/2010WO2010054807A1 Protein with promoting effects for axonal growth of neurons of central nervous system
05/20/2010WO2010054639A2 Method for collecting oral mucosa skin cells and/or cell fragments
05/20/2010WO2010054530A1 Method for preparing genetically engineered n-terminal acetylated thymosin alpha 1
05/20/2010WO2010054513A1 A thermotolerant non-k12 escherichia coli phytase and its production
05/20/2010WO2010054503A1 Anticoagulant polypeptides and uses thereof
05/20/2010WO2010034487A3 Means for inhibiting the expression of orc-1
05/20/2010WO2010033321A3 Novel bacillus thuringiensis gene with lepidopteran activity
05/20/2010WO2010033320A3 Novel bacillus thuringiensis gene with coleopteran activity
05/20/2010WO2010027948A3 Methods and compositions for increased alpha-prime beta-conglycinin soybeans
05/20/2010WO2010027506A3 Genetically engineered herbicide resistance for maintaining axenic cultures
05/20/2010WO2010025213A8 Methods for increasing grain value and compositions thereof
05/20/2010WO2010023320A3 Plants having enhanced yield-related traits and a method for making the same
05/20/2010WO2010022195A3 Non-integrating lenti/adeno-associated virus hybrid vector system
05/20/2010WO2010022098A3 Dna methylation detection methods
05/20/2010WO2010017540A3 Geobacter strains that use alternate organic compounds, methods of making, and methods of use thereof
05/20/2010WO2010014946A3 Halogen-stabilized insulin
05/20/2010WO2010003065A3 Axmi-il 5, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
05/20/2010WO2010003007A3 Compositions and methods for producing isoprene free of c5 hydrocarbons under decoupling conditions and/or safe operating ranges
05/20/2010WO2009152500A4 Methods and compositions for mediating gene silencing
05/20/2010WO2009145573A9 Recombinant escherichia coli for producing recombinant human variation interferon-beta proteins wherein methionine at the amino end is removed, and preparation method thereof
05/20/2010WO2009073103A3 Simian subfamily b adenoviruses sadv-28,27,-29,-32,-33, and -35 and uses thereof
05/20/2010WO2008103248A8 Ketoreductases and uses thereof
05/20/2010US20100125918 Enterovirus type 71 protein and method for production
05/20/2010US20100125917 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE
05/20/2010US20100125131 Gene Encoding A Guanine Nucleotide Exchange Factor And The Gene Product Thereof
05/20/2010US20100125130 Tumour necrosis factor binding ligands
05/20/2010US20100125127 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation
05/20/2010US20100125101 Immunostimulatory nucleic acid molecules
05/20/2010US20100125100 GOLD NANOROD-siRNA COMPLEXES AND METHODS OF USING SAME
05/20/2010US20100125099 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
05/20/2010US20100124777 Bacterium producing L-glutamic acid and method for producing L-glutamic acid
05/20/2010US20100124768 Compositions and methods for the assembly of polynucleotides
05/20/2010US20100124767 Microarray Synthesis and Assembly of Gene-Length Polynucleotides
05/20/2010US20100124740 Somatic transfer of modified genes to predict drug effects
05/20/2010US20100124556 Novel shigella protein antigens and methods
05/20/2010US20100124551 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
05/20/2010US20100124547 Compositions and methods for inhibiting expression of factor vii genes
05/20/2010CA2852487A1 Bifidobacterium longum
05/20/2010CA2852479A1 Bifidobacterium longum
05/20/2010CA2743853A1 Novel hiv-2 isolate
05/20/2010CA2743775A1 .beta.gi-igg intron for enhanced anti-igf1r expression
05/20/2010CA2743711A1 A thermotolerant non-k12 escherichia coli phytase and its production
05/20/2010CA2743668A1 Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo
05/20/2010CA2743666A1 Optically-based stimulation of target cells and modifications thereto
05/20/2010CA2743505A1 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof
05/20/2010CA2743473A1 Methods and compositions of molecular profiling for disease diagnostics
05/20/2010CA2743464A1 Therapeutic and diagnostic methods relating to cancer stem cells
05/20/2010CA2743329A1 Antisense compositions and methods of making and using same
05/20/2010CA2743302A1 Proteases comprising one or more combinable mutations
05/20/2010CA2743249A1 Compositions and methods for inhibiting expression of factor vii genes
05/20/2010CA2742846A1 Releasable fusogenic lipids for nucleic acids delivery systems
05/20/2010CA2742786A1 Humanized anti-il-6 antibodies
05/20/2010CA2742763A1 E. coli mediated gene silencing of beta-catenin
05/20/2010CA2742689A1 Branched cationic lipids for nucleic acids delivery system
05/20/2010CA2742272A1 Products and processes for multiplex nucleic acid identification
05/20/2010CA2741973A1 Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same
05/20/2010CA2741006A1 Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants
05/20/2010CA2740714A1 Vectors
05/19/2010EP2187213A1 Method for detecting interactions between two and more biological macromolecules
05/19/2010EP2186905A1 Method of producing heterogeneous protein
05/19/2010EP2186903A2 Expression cassettes for regulation of expression in monocotyledonous plants
05/19/2010EP2186902A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
05/19/2010EP2186901A2 Mutations in the BCR-Abl-tyrosine kinase associated with resistance to STI-571
05/19/2010EP2186900A2 Variants of ADP-Glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
05/19/2010EP2186899A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
05/19/2010EP2186898A1 Flowering induction
05/19/2010EP2186897A1 An improved method for synthesising templated molecules
05/19/2010EP2186896A1 Cancer antigen peptides derived from WT1
05/19/2010EP2186895A1 Method for detecting and quantifying endogenous wheat DNA sequence
05/19/2010EP2186894A1 Monoclonal antibody having neutralizing activity against mmp13
05/19/2010EP2186893A1 Production and use of epitope-tagged hepatitis c virus particle
05/19/2010EP2186892A1 Anti-cd20 monoclonal antibodies
05/19/2010EP2186891A1 Yeast for transformation, transformation method and method of producing substance
05/19/2010EP2186890A1 Method for production of biofilm
05/19/2010EP2186888A1 Transgenic non-human animals capable of producing heterologous antibodies
05/19/2010EP2186884A2 HCV-anti-core monoclonal antibody
05/19/2010EP2186880A1 Improved production of riboflavin
05/19/2010EP2186879A2 High sensitivity quantitation of peptides by mass spectrometry
05/19/2010EP2186821A1 Protein with promoting effects for axonal growth of neurons of central nervous system
05/19/2010EP2186820A1 Protein-protein interactions in human immunodeficiency virus
05/19/2010EP2186801A2 Intermediates for synthesizing dibenzorhodamine dyes
05/19/2010EP2186530A1 Promoters exhibiting endothelial cell specificity and methods of using same
05/19/2010EP2186528A1 Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor
05/19/2010EP2186526A1 Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action
05/19/2010EP2186524A1 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/19/2010EP2186402A1 Knock-out animal models for novel genes and methods of use
05/19/2010EP2185933A2 Matriptase protein and uses thereof
05/19/2010EP2185930A1 Interaction screening methods, systems and devices
05/19/2010EP2185732A1 Cancer associated gene ly6k
05/19/2010EP2185730A1 Methods and compositions for diagnosing disease
05/19/2010EP2185729A1 Method of identifying individuals at risk of thiopurine drug resistance and intolerance
05/19/2010EP2185723A1 Genetic variation in pro-melanin-concentrating hormone gene affects carcass traits in cattle
05/19/2010EP2185716A2 Improved t7 expression system
05/19/2010EP2185711A2 Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system
05/19/2010EP2185710A1 Eukaryotic promoters for gene expression
05/19/2010EP2185709A1 CELL PERMEABLE p18 RECOMBINANT PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME, AND ANTICANCER COMPOSITION COMPRISING THE SAME
05/19/2010EP2185708A1 Methods and organisms for the growth-coupled production of 1,4-butanediol
05/19/2010EP2185707A2 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
1 ... 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 ... 4023